Page 89 - MemoriaSAM

www.cibersam.es

á

Publicaciones • MuguruzA C, lehTonen M, AAlTonen n, MorenTin B, MeAnA JJ, CAllAdo lF. Quantification
of endocannabinoids in postmortem brain of schizophrenic subjects.Schizophr Res.
científicas
2013 Aug;148(1-3):145-50.
ms relevantes
• SánChez P, PeñA J, BengoeTXeA e, oJedA n, elizAgárATe e, ezCurrA J eT Al.. Improvements
in Negative Symptoms and Functional Outcome After a New Generation Cognitive

Remediation Program: A Randomized Controlled Trial.Schizophr Bull. 2013 May 18;.

• Fernández-PASTor B, orTegA Je, MeAnA JJ. Involvement of serotonin 5-HT3 recep-
tors in the modulation of noradrenergic transmission by serotonin reuptake in-

hibitors: a microdialysis study in rat brain.Psychopharmacology (Berl). 2013
Sep;229(2):331-44.

• KuriTA M, Moreno Jl, hollowAy T, KozlenKoV A, MoCCi g, gArCíA-BeA A eT Al.. Repressive
epigenetic changes at the mGlu2 promoter in frontal cortex of 5-HT2A knockout

mice.Mol Pharmacol. 2013 Jun;83(6):1166-75.

• PinACho r, VillAlMAnzo n, roCA M, inieSTA r, MonJe A, hAro JM eT Al.. Analysis of Sp
transcription factors in the postmortem brain of chronic schizophrenia: a pilot study

of relationship to negative symptoms.J Psychiatr Res. 2013 Jul;47(7):926-34.

• 10 publicaciones internacionales.
A destacar

13
0
2
AL
NU
A
A
RI
O
EM
M
/
M
SA
R
BE
CI

89